Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cytiva Sweden Trading AB
AB
Active
Org 5593527517
Danmarksgatan 39, 753 23
Uppsala
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2021
45 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Cytiva Sweden Trading AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
139M
279M
418M
558M
0M
2022
226M
2023
485M
2024
EBITDA
SEK millions
0M
9M
18M
27M
36M
0M
2022
24M
2023
31M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
0
226 401
484 540
Staff expenses
—
—
—
EBITDA
−2
24 045
31 249
Depreciation & amort.
−0
−10 509
−13 557
EBIT
−2
13 536
17 692
Net financials
—
763
2 736
Profit before tax
−2
14 299
20 428
Tax
−0
−204
−2 931
Net profit
−2
14 095
17 497
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
23
329 535
269 874
Equity
23
288 184
155 680
Long-term debt
0
0
0
Short-term debt
0
40 823
110 871
Total debt
—
40 823
110 871
Financial ratios
5-year trend
EBITDA margin
6.4%
This company
15.8%
Market median
-59% vs market
2022
2024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
2022
2024
Return on equity
11.2%
This company
18.4%
Market median
+39% vs market
2022
2024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
2022
2024
Asset turnover
1.80×
This company
1.12×
Market median
+61% vs market
2022
2024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-12-31
View
PDF
More on Cytiva Sweden Trading AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
